WAT - Waters announces Euro6M R&D investment at Wexford facility
- Waters ( NYSE: WAT ) has announced a multi-year investment of up to €6M with support from IDA Ireland to expand its operations in Drinagh, Wexford.
- The analytical instruments firm is expanding its R&D operations for clinical diagnostics at its Wexford facility. The facility serves as a primary site for manufacturing and delivery of its portfolio of in-vitro diagnostic systems, reagent kits, and software.
- The expansion will create new scientific jobs focused on solutions for broader clinical diagnostic applications through 2024. The facility currently employs over 400 people.
For further details see:
Waters announces €6M R&D investment at Wexford facility